BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT

Beltran Pedro sold 1,870 BridgeBio Oncology Therapeutics, Inc. shares (Form 4)

Traded Nov 18, 2026 · Filed Nov 20, 2026

On Nov 18, 2026, Beltran Pedro (Director, President and CEO) sold 1,870 BridgeBio Oncology Therapeutics, Inc. shares at US$1.84 for US$3,443 under a trading plan, leaving 41,659 shares. Filed Nov 20, 2026 (Form 4).

Sold
1,870 shares
Price
US$1.84
Value
US$3,443
Holding after
41,659 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 18, 2026Common StockSale1,870US$1.8441,659Direct

Source

Download original · View original at SEC

Related